Skip to main navigation Skip to search Skip to main content

Expanding the use of abiraterone in prostate cancer: Is earlier always better?

Keith T. Schmidt, Ravi A. Madan, William D. Figg*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Expanding the use of abiraterone in prostate cancer: Is earlier always better?'. Together they form a unique fingerprint.
Sort by

Medicine & Life Sciences